Europe Immunohistochemistry Market

Europe Immunohistochemistry Market Size (2023 to 2028)

The size of Europe IHC Market was worth USD 508.00 million in 2023 and estimated to be growing at a CAGR of 7.45%, to reach USD 727.60 million by 2028.

Immunohistochemistry is a diagnosis process in which a fresh or stored cancer tissue that is removed out during biopsy is stained. This diagnostic method helps in checking the presence of hormone receptors on the surfaces of cancer cells. Immunohistochemistry is mainly used for the diagnosis of cancers, especially tumor antibodies. It is a vital application in medicine as it helps doctors know the tissue distribution of an antibody.

The developing healthcare infrastructure, rising disposable income, and advancement in medical technology are driving the growth of the Immunotherapy market in Europe. The growing prevalence of cancer actively encourages this region, and various other chronic diseases are also majorly propelling the market growth. Immunohistochemistry has immense popularity in the area of clinical diagnostics, which is used in the diagnosis of chronic diseases such as infectious diseases, cardiovascular diseases, cancer, and autoimmune disorders, and others.

However, huge capital and time requirements and uncertain reimbursement scenarios are significant factors that hamper the growth of this market. Several limitations related to immunohistochemistry techniques and the expensive cost of automated IHC instruments are anticipated to restrains market growth in Europe. Automated immunohistochemistry instruments for disease diagnosis take high setup costs are hindering the market growth.

This research report on European Immunohistochemistry Market has been segmented and sub-segmented into the following categories:

By Product: 

• Antibodies
• Reagents
• Equipment
• Kits

By Application: 

• Diagnostics
• Drug Testing

By End User: 

• Hospitals
• Diagnostic Laboratories
• Research Institutes

By Country: 

• UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic, and Rest of Europe.

Regional Analysis:

European IHC Market was the world’s second-leading regional market in 2019, and the United Kingdom Immunohistochemistry market was the top-performing regional market in Europe. Factors such as rising drug discovery and development activities and the increasing prevalence of chronic diseases are anticipated to drive the immunohistochemistry (IHC) market growth in the U.K.

The German Immunohistochemistry market shows significant growth due to the rising number of diagnostic centers. Increasing physician awareness and demand for histopathology are anticipated to fuel the growth of this market in the coming years. Additional to this, rapid technological developments in the IVD industry and increasing healthcare expenditure are expected to fuel this market's growth.

Promising Companies Operating the Europe Immunohistochemistry Market Profiled in the Report are F. Hoffmann-La Roche AG, Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Merck Millipore, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Abcam plc, Cell Signaling Technology, Inc., and Bio SB Inc.